SCHEMBL4694014

SCHEMBL4694014

Clc1ccc(-c2cncnc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.56
CYP19A1 P11511 7/20 0.52
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2A6 P11509 2/20 0.46
MAP4K4 O95819 1/20 0.46
XDH P47989 1/20 0.45
NOTUM Q6P988 1/20 0.45
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
HSD11B1 P28845 1/20 0.44
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
GAA P10253 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
AHR P35869 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6682176 0.86 ATM (0.72) ATMCYP1A2CYP3A4CYP2D6CYP2A6
SCHEMBL19741332 0.80 CNR1 (0.50) ATMCYP19A1CYP1A2MAP4K4CNR1
SCHEMBL7809471 0.77 CYP19A1 (0.46) ATMCYP19A1CYP3A4CYP2D6MAP4K4
SCHEMBL3952742 0.76 CYP1A2 (0.73) CYP1A2CYP3A4CYP2A6NOTUMNPC1
SCHEMBL28215 0.76 CYP1A2 (0.73) CYP1A2CYP3A4CYP2A6NOTUMNPC1
SCHEMBL11165087 0.76 CYP1A2 (0.73) CYP1A2CYP3A4CYP2A6NOTUMNPC1
SCHEMBL2814958 0.76 ATM (0.65) ATMCYP1A2CYP3A4CYP2D6CYP2A6
SCHEMBL2553484 0.74 ATM (0.56) ATMCYP19A1CYP2A6XDHNPC1
SCHEMBL20723166 0.74 ATM (0.56) ATMCYP3A4CYP2D6CYP2A6XDH
SCHEMBL10356485 0.74 ESR1 (0.58) ATMCYP19A1CYP3A4CYP2A6XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105461699-B Substituted heterocyclic compound and its application method and purposes 广东东阳光药业有限公司 2019-07-09 CN disclosed
CN-102014900-B Method of treating cancer using a neuropeptide Y5R (NPY5R) antagonist UNIV HEALTH NETWORK 2014-04-02 CN disclosed
CN-101638352-B Preparation method of aryl-substituted nitrogen heterocyclic compound UNIV DALIAN TECH 2011-08-31 CN disclosed
CN-102014900-A Method of treating cancer using a neuropeptide Y5R (NPY5R) antagonist UNIV HEALTH NETWORK 2011-04-13 CN disclosed
CN-101638352-A Preparation method of aryl-substituted nitrogen heterocyclic compound UNIV DALIAN TECH 2010-02-03 CN disclosed
EP-1871762-A2 SUBTITUTED HETEROARYL CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2008-01-02 EP disclosed
CN-101027075-A Combination therapy for the treatment of obesity MERCK & CO INC (US) 2007-08-29 CN disclosed
WO-2006113704-A2 SUBTITUTED HETEROARYL CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2006-10-26 WO disclosed